Seegene Inc - Asset Resilience Ratio

Latest as of September 2025: 28.16%

Seegene Inc (096530) has an Asset Resilience Ratio of 28.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 096530 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩342.92 Billion
≈ $232.39 Million USD Cash + Short-term Investments

Total Assets

₩1.22 Trillion
≈ $825.33 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Seegene Inc's Asset Resilience Ratio has changed over time. See 096530 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Seegene Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Seegene Inc market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩342.92 Billion 28.16%
Total Liquid Assets ₩342.92 Billion 28.16%

Asset Resilience Insights

  • Very High Liquidity: Seegene Inc maintains exceptional liquid asset reserves at 28.16% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Seegene Inc Industry Peers by Asset Resilience Ratio

Compare Seegene Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Spyre Therapeutics Inc.
NASDAQ:SYRE
Biotechnology 84.34%
3SBio Inc
F:83B
Biotechnology 10.64%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
Biotechnology 0.02%
Novavax Inc
NASDAQ:NVAX
Biotechnology 53.87%
BB Biotech AG
SW:BION
Biotechnology 0.05%

Annual Asset Resilience Ratio for Seegene Inc (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Seegene Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 21.81% ₩262.92 Billion
≈ $178.17 Million
₩1.21 Trillion
≈ $816.80 Million
-4.60pp
2023-12-31 26.41% ₩330.50 Billion
≈ $223.98 Million
₩1.25 Trillion
≈ $848.09 Million
-17.00pp
2022-12-31 43.41% ₩603.78 Billion
≈ $409.17 Million
₩1.39 Trillion
≈ $942.51 Million
+11.63pp
2021-12-31 31.78% ₩473.45 Billion
≈ $320.85 Million
₩1.49 Trillion
≈ $1.01 Billion
+2.43pp
2020-12-31 29.35% ₩321.26 Billion
≈ $217.71 Million
₩1.09 Trillion
≈ $741.78 Million
+1.75pp
2019-12-31 27.60% ₩54.01 Billion
≈ $36.60 Million
₩195.72 Billion
≈ $132.63 Million
+4.73pp
2018-12-31 22.87% ₩37.46 Billion
≈ $25.39 Million
₩163.81 Billion
≈ $111.01 Million
+0.02pp
2017-12-31 22.85% ₩37.66 Billion
≈ $25.52 Million
₩164.84 Billion
≈ $111.71 Million
-12.70pp
2016-12-31 35.55% ₩73.80 Billion
≈ $50.01 Million
₩207.62 Billion
≈ $140.70 Million
+22.05pp
2015-12-31 13.50% ₩26.19 Billion
≈ $17.75 Million
₩194.05 Billion
≈ $131.50 Million
+5.12pp
2014-12-31 8.38% ₩11.60 Billion
≈ $7.86 Million
₩138.45 Billion
≈ $93.83 Million
+1.40pp
2013-12-31 6.97% ₩9.00 Billion
≈ $6.10 Million
₩129.04 Billion
≈ $87.45 Million
-2.75pp
2012-12-31 9.73% ₩8.13 Billion
≈ $5.51 Million
₩83.62 Billion
≈ $56.67 Million
--
pp = percentage points

About Seegene Inc

KQ:096530 Korea Biotechnology
Market Cap
$900.01 Million
₩1.33 Trillion KRW
Market Cap Rank
#9537 Global
#259 in Korea
Share Price
₩28800.00
Change (1 day)
-2.37%
52-Week Range
₩21850.00 - ₩35150.00
All Time High
₩140042.88
About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection … Read more